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Background: We have previously demonstrated that uric acid (UA)-associated increase in incident heart failure (HF) occurs only in those without 
chronic kidney disease (CKD). We hypothesized that hyperuricemia in those without CKD is primarily due to increased UA production and thus a 
marker of increased xanthine oxidase (XO) activity and that in those with CKD, it is largely due to its impaired renal excretion and thus not a marker 
of XO activity. To further test this hypothesis, we examined the effect of UA on incident HF in subjects with normal and high serum insulin levels as 
renal elimination of UA is impaired in hyperinsulinemia.
Methods: Of the 5411 ambulatory community dwelling older adults age ≥65 years, without baseline HF and with data on baseline serum insulin 
levels in the Cardiovascular Health Study (CHS), 2731 (51%) had serum insulin ≥13 pg/ml (median). Propensity scores for hyperuricemia (UA ≥6 
mg/dL for women and ≥8 mg/dL for men) were calculated for each patient and were used a composite marker for 63 baseline characteristics. 
Propensity-adjusted hazard ratios (when hyperuricemia was compared with normal serum UA) for centrally adjudicated incident HF were estimated, 
separately in those with and without hyperinsulinemia.
Results: Mean serum UA levels for subject with and without hyperinsulinemia were 6.0 and 5.3 mg/dL respectively (P<0.0001). Propensity-
adjusted hazard ratios associated with hyperuricemia for incident HF were 0.98 (95% confidence intervals, 0.82-1.17; P=0.822) and 1.33 (95% 
confidence intervals, 1.05-1.68; P=0.018) respectively for subjects with and without hyperinsulinemia (Propensity-adjusted P for interaction, 0.015).
Conclusion: Despite similar sample size for subjects with and without hyperinsulinemia, and a higher mean serum UA level in those with 
hyperinsulinemia, hyperuricemia had no association with incident HF in those with hyperinsulinemia but significantly increased the risk of incident 
HF in those without hyperinsulinemia. These findings suggest that hyperuricemia has no intrinsic effect on cardiovascular events and may only 
predict incident HF when it is a marker of increased XO activity, but not when it is due to impaired renal excretion of UA.
